niche industry
information & intelligence
on drug delivery logo

check it out in the new online viewer! -->

Issue N°48, April 10th 2014

Ophthalmic Drug Delivery
(Inaugural Issue)

DOWNLOAD COMPLETE ISSUE: LO RES PDF (6MB FILE)

DOWNLOAD COMPLETE ISSUE: HI RES PDF (10MB FILE)

CONTENTS:

Ocular Drug Delivery: Review of Present
Technologies & Steps Forward

Dr Shikha P Barman, CEO & CTO
Integral BioSystems, LLC

ARTICLE PDF

Company Profile
GrayBug, LLC

PROFILE PDF

Improving Outcomes in Ophthalmology
via Sustained Drug Delivery

Dr Tomas Navratil, Vice-President, Development
Dr Benjamin Maynor, Vice-President, Research
& Dr Benjamin Yerxa, Chief Scientific Officer
Envisia Therapeutics, Inc

ARTICLE PDF

Breakthrough Nanotechnology Enhances Delivery to the Front and Back of the Eye
Dr Hongming Chen, Executive Vice-President of Research
Dr Robert Langer, Co-Founder and Board Member
Kala Pharmaceuticals, Inc

ARTICLE PDF

Zero-Order Sustained Drug Delivery to the Retina
from a Nanoporous Film Device

Dr Daniel A Bernards, Specialist, Department of Bioengineering & Therapeutic Sciences, UCSF
Dr Robert B Bhisitkul, Professor, Department of Ophthalmology, UCSF
Dr Tejal Desai, Professor and Vice-Chair, Department of Bioengineering & Therapeutic Sciences, UCSF
Zordera, Inc

ARTICLE PDF

Company Profile
Encompass Ophthalmic Drug Development Services

PROFILE PDF

Micro Ophthalmic Ocular Implants
Ms Donna Bibber, Chief Executive Officer
Micro Engineering Solutions, LLC

ARTICLE PDF

Current and Future Ophthalmic Formulation and Process Development Trends
Mr Brian McMillan, Vice-President Product Development
CoreRx, Inc

ARTICLE PDF

Ophthalmic Product Development: Reduce Risks, Mitigate Failure & Drive Timelines in a Competitive Market
Mr Badre Hammond, Global Head of Business Development
Next Breath, LLC

ARTICLE PDF

DOWNLOAD COMPLETE ISSUE: LO RES PDF (6MB FILE)

DOWNLOAD COMPLETE ISSUE: HI RES PDF (10MB FILE)

Subscribe Today!